These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 25217292)

  • 1. Plasma amyloid-β and risk of Alzheimer's disease in the Framingham Heart Study.
    Chouraki V; Beiser A; Younkin L; Preis SR; Weinstein G; Hansson O; Skoog I; Lambert JC; Au R; Launer L; Wolf PA; Younkin S; Seshadri S
    Alzheimers Dement; 2015 Mar; 11(3):249-57.e1. PubMed ID: 25217292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma beta-amyloid and duration of Alzheimer's disease in adults with Down syndrome.
    Prasher VP; Sajith SG; Mehta P; Zigman WB; Schupf N
    Int J Geriatr Psychiatry; 2010 Feb; 25(2):202-7. PubMed ID: 19513990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma β amyloid and the risk of Alzheimer's disease in Down syndrome.
    Coppus AM; Schuur M; Vergeer J; Janssens AC; Oostra BA; Verbeek MM; van Duijn CM
    Neurobiol Aging; 2012 Sep; 33(9):1988-94. PubMed ID: 21958962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma amyloid-β levels, cerebral atrophy and risk of dementia: a population-based study.
    Hilal S; Wolters FJ; Verbeek MM; Vanderstichele H; Ikram MK; Stoops E; Ikram MA; Vernooij MW
    Alzheimers Res Ther; 2018 Jun; 10(1):63. PubMed ID: 29960604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New assay for old markers-plasma beta amyloid of mild cognitive impairment and Alzheimer's disease.
    Chiu MJ; Yang SY; Chen TF; Chieh JJ; Huang TZ; Yip PK; Yang HC; Cheng TW; Chen YF; Hua MS; Horng HE
    Curr Alzheimer Res; 2012 Dec; 9(10):1142-8. PubMed ID: 22950866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Relationship Between Plasma Aβ Levels, Cognitive Function and Brain Volumetrics: Sydney Memory and Ageing Study.
    Poljak A; Crawford JD; Smythe GA; Brodaty H; Slavin MJ; Kochan NA; Trollor JN; Wen W; Mather KA; Assareh AA; Ng PC; Sachdev PS
    Curr Alzheimer Res; 2016; 13(3):243-55. PubMed ID: 26679856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma amyloid levels within the Alzheimer's process and correlations with central biomarkers.
    Hanon O; Vidal JS; Lehmann S; Bombois S; Allinquant B; Tréluyer JM; Gelé P; Delmaire C; Blanc F; Mangin JF; Buée L; Touchon J; Hugon J; Vellas B; Galbrun E; Benetos A; Berrut G; Paillaud E; Wallon D; Castelnovo G; Volpe-Gillot L; Paccalin M; Robert PH; Godefroy O; Dantoine T; Camus V; Belmin J; Vandel P; Novella JL; Duron E; Rigaud AS; Schraen-Maschke S; Gabelle A;
    Alzheimers Dement; 2018 Jul; 14(7):858-868. PubMed ID: 29458036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Midlife blood pressure, plasma β-amyloid, and the risk for Alzheimer disease: the Honolulu Asia Aging Study.
    Shah NS; Vidal JS; Masaki K; Petrovitch H; Ross GW; Tilley C; DeMattos RB; Tracy RP; White LR; Launer LJ
    Hypertension; 2012 Apr; 59(4):780-6. PubMed ID: 22392902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma beta amyloid and the risk of Alzheimer disease and dementia in elderly men: a prospective, population-based cohort study.
    Sundelöf J; Giedraitis V; Irizarry MC; Sundström J; Ingelsson E; Rönnemaa E; Arnlöv J; Gunnarsson MD; Hyman BT; Basun H; Ingelsson M; Lannfelt L; Kilander L
    Arch Neurol; 2008 Feb; 65(2):256-63. PubMed ID: 18268197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study.
    de Wolf F; Ghanbari M; Licher S; McRae-McKee K; Gras L; Weverling GJ; Wermeling P; Sedaghat S; Ikram MK; Waziry R; Koudstaal W; Klap J; Kostense S; Hofman A; Anderson R; Goudsmit J; Ikram MA
    Brain; 2020 Apr; 143(4):1220-1232. PubMed ID: 32206776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The free plasma amyloid Aβ
    Schraen-Maschke S; Duhamel A; Vidal JS; Ramdane N; Vaudran L; Dussart C; Buée L; Sablonnière B; Delaby C; Allinquant B; Gabelle A; Bombois S; Lehmann S; Hanon O;
    Neurobiol Dis; 2024 Apr; 193():106459. PubMed ID: 38423192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased prediction value of biomarker combinations for the conversion of mild cognitive impairment to Alzheimer's dementia.
    Zhao A; Li Y; Yan Y; Qiu Y; Li B; Xu W; Wang Y; Liu J; Deng Y
    Transl Neurodegener; 2020 Aug; 9(1):30. PubMed ID: 32741361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross-sectional and longitudinal study in the AIBL cohort.
    Chatterjee P; Pedrini S; Doecke JD; Thota R; Villemagne VL; Doré V; Singh AK; Wang P; Rainey-Smith S; Fowler C; Taddei K; Sohrabi HR; Molloy MP; Ames D; Maruff P; Rowe CC; Masters CL; Martins RN;
    Alzheimers Dement; 2023 Apr; 19(4):1117-1134. PubMed ID: 36574591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma concentrations of free amyloid β cannot predict the development of Alzheimer's disease.
    Lövheim H; Elgh F; Johansson A; Zetterberg H; Blennow K; Hallmans G; Eriksson S
    Alzheimers Dement; 2017 Jul; 13(7):778-782. PubMed ID: 28073031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of plasma amyloid-β levels in Alzheimer's disease.
    Song F; Poljak A; Valenzuela M; Mayeux R; Smythe GA; Sachdev PS
    J Alzheimers Dis; 2011; 26(2):365-75. PubMed ID: 21709378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical significance of plasma clusterin and Aβ in the longitudinal follow-up of patients with Alzheimer's disease.
    Hsu JL; Lee WJ; Liao YC; Wang SJ; Fuh JL
    Alzheimers Res Ther; 2017 Nov; 9(1):91. PubMed ID: 29169407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of plasma Aβ as predictor of Alzheimer's disease in older individuals without dementia: a population-based study.
    Hansson O; Stomrud E; Vanmechelen E; Östling S; Gustafson DR; Zetterberg H; Blennow K; Skoog I
    J Alzheimers Dis; 2012; 28(1):231-8. PubMed ID: 21955816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of plasma β-amyloid with MRI markers of structural brain aging the 3-City Dijon study.
    Kaffashian S; Tzourio C; Soumaré A; Dufouil C; Mazoyer B; Schraen-Maschke S; Buée L; Debette S
    Neurobiol Aging; 2015 Oct; 36(10):2663-70. PubMed ID: 26242707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of plasma Aβ levels to dementia in aging individuals with mild cognitive impairment.
    Fei M; Jianghua W; Rujuan M; Wei Z; Qian W
    J Neurol Sci; 2011 Jun; 305(1-2):92-6. PubMed ID: 21440911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma amyloid-beta forms in Alzheimer's disease and non-Alzheimer's disease patients.
    Le Bastard N; Leurs J; Blomme W; De Deyn PP; Engelborghs S
    J Alzheimers Dis; 2010; 21(1):291-301. PubMed ID: 20421698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.